1. Home
  2. SCM vs RNAC Comparison

SCM vs RNAC Comparison

Compare SCM & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCM
  • RNAC
  • Stock Information
  • Founded
  • SCM 2012
  • RNAC 2007
  • Country
  • SCM United States
  • RNAC United States
  • Employees
  • SCM N/A
  • RNAC N/A
  • Industry
  • SCM Finance/Investors Services
  • RNAC Biotechnology: Pharmaceutical Preparations
  • Sector
  • SCM Finance
  • RNAC Health Care
  • Exchange
  • SCM Nasdaq
  • RNAC Nasdaq
  • Market Cap
  • SCM 370.0M
  • RNAC 422.4M
  • IPO Year
  • SCM 2012
  • RNAC 2016
  • Fundamental
  • Price
  • SCM $13.39
  • RNAC $18.48
  • Analyst Decision
  • SCM Hold
  • RNAC Strong Buy
  • Analyst Count
  • SCM 2
  • RNAC 7
  • Target Price
  • SCM $13.63
  • RNAC $41.60
  • AVG Volume (30 Days)
  • SCM 159.7K
  • RNAC 113.3K
  • Earning Date
  • SCM 11-07-2024
  • RNAC 11-07-2024
  • Dividend Yield
  • SCM 12.07%
  • RNAC N/A
  • EPS Growth
  • SCM 307.51
  • RNAC N/A
  • EPS
  • SCM 1.96
  • RNAC N/A
  • Revenue
  • SCM $107,143,385.00
  • RNAC $47,938,000.00
  • Revenue This Year
  • SCM $0.17
  • RNAC $56.06
  • Revenue Next Year
  • SCM N/A
  • RNAC N/A
  • P/E Ratio
  • SCM $6.75
  • RNAC N/A
  • Revenue Growth
  • SCM 5.88
  • RNAC N/A
  • 52 Week Low
  • SCM $12.48
  • RNAC $11.67
  • 52 Week High
  • SCM $14.68
  • RNAC $41.87
  • Technical
  • Relative Strength Index (RSI)
  • SCM 27.88
  • RNAC 40.64
  • Support Level
  • SCM $13.12
  • RNAC $17.72
  • Resistance Level
  • SCM $13.95
  • RNAC $26.50
  • Average True Range (ATR)
  • SCM 0.16
  • RNAC 2.26
  • MACD
  • SCM -0.06
  • RNAC -0.45
  • Stochastic Oscillator
  • SCM 19.88
  • RNAC 0.00

About SCM Stellus Capital Investment Corporation

Stellus Capital Investment Corp is a closed-end, non-diversified management investment company. Its objective is to maximize the total return to its stockholders in the form of current income and capital appreciation. It invests in private middle-market companies through a first lien, second lien, and unsecured debt financing, often with a corresponding equity investment. The company invests in various sectors, such as business services, energy, general industrial, government services, healthcare, software, and specialty finance. Business activity of the firm is functioned through the United States and it generates revenue in the form of interest income on debt investments and capital gains and distributions.

About RNAC Cartesian Therapeutics Inc.

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. It leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Share on Social Networks: